(Q36928229)

17 August 2017

1 reference

title

Immune markers in hematologic malignancies (English)

1 reference

17 August 2017

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

21 November 2022

author name string

L. Vaickus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1777090

21 November 2022

E. D. Ball

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1777090

21 November 2022

K. A. Foon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1777090

21 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1777090

21 November 2022

publication date

1 December 1991

1 reference

full work available at URL

17 August 2017

https://api.elsevier.com/content/article/PII:104084289190029C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

https://api.elsevier.com/content/article/PII:104084289190029C?httpAccept=text/plain

21 November 2022

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Critical Reviews in Oncology Hematology

21 November 2022

published in

1 reference

17 August 2017

volume

11

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

267-297

1 reference

Report from Vienna: in search of all surface molecules expressed on human leukocytes

17 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Towards a better definition of human leucocyte surface molecules.

21 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro

21 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The human T cell receptor genes are targets for chromosomal abnormalities in T cell tumors

21 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Structure, organization, and somatic rearrangement of T cell gamma genes

21 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Identification of a putative second T-cell receptor.

21 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

A new T-cell receptor gene located within the alpha locus and expressed early in T-cell differentiation

21 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Two forms of the T-cell receptor gamma protein found on peripheral blood cytotoxic T lymphocytes

21 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

CD3-negative natural killer cells express ε TCR as part of a novel molecular complex

21 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Familial defect in the surface expression of the T-cell receptor-CD3 complex

21 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

A unique T-cell receptor complex expressed on human fetal lymphocytes displaying natural-killer-like activity

21 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Rearrangement of the T-cell receptor beta-chain gene in non-T-cell, non-B-cell acute lymphoblastic leukemia of childhood

21 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Regulation of the assembly and expression of variable-region genes

21 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

T cell receptor gamma and delta rearrangements in hematologic malignancies. Relationship to lymphoid differentiation

21 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells

21 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The regulation of intracellular signals during lymphocyte activation

21 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The molecules controlling B lymphocytes

21 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Antigens on human plasma cells identified by monoclonal antibodies

21 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

21 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Identification and cloning of a prethymic precursor T lymphocyte from a population of common acute lymphoblastic leukemia antigen (CALLA)-positive fetal bone marrow cells

21 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Regulation of T-cell receptor gene expression in human T-cell development

21 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures

21 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3)

21 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Functional and molecular characteristics of T-cell growth factor

21 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Expression of a 26,000-dalton glycoprotein on activated human T cells

21 November 2022

66

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunophenotype of clonogenic cells in myeloid leukaemia

21 November 2022

72

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Laboratory and clinical applications of monoclonal antibodies for leukemias and non-Hodgkin's lymphomas

21 November 2022

74

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunodiagnosis of acute nonlymphocytic leukemia

21 November 2022

75

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 November 2022

84

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Classification of Acute Leukemia

21 November 2022

85

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Antisera to acute lymphoblastic leukemia cells

21 November 2022

86

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Expression of the OKT monoclonal antibody defined antigenic determinants in malignancy

21 November 2022

87

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Acute lymphoblastic leukaemia in children: Classification and prognosis

21 November 2022

88

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunological Classification of Acute Lymphoblastic Leukaemias: Evaluation of its Clinical Significance in a Hundred Patients

21 November 2022

90

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study

21 November 2022

97

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells

21 November 2022

98

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins.

21 November 2022

99

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation

21 November 2022

100

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Characterization of immunoglobulin and T-cell receptor gene patterns in B-cell precursor acute lymphoblastic leukemia of childhood.

21 November 2022

101

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Rearrangement of the T-cell receptor beta-chain gene in non-T-cell, non-B-cell acute lymphoblastic leukemia of childhood

21 November 2022

102

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunoglobulin and T-cell receptor gene rearrangement and expression in human lymphoid leukemia cells at different stages of maturation

21 November 2022

103

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

T cell receptor alpha-chain gene rearrangements in B-precursor leukemia are in contrast to the findings in T cell acute lymphoblastic leukemia. Comparative study of T cell receptor gene rearrangement in childhood leukemia

21 November 2022

104

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders

21 November 2022

105

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies

21 November 2022

115

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and non-haemopoietic distribution using panels of monoclonal antibodies belonging to CD-11b, CD-13 and CD-33.

21 November 2022

116

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Contribution of immunophenotype to the classification and differential diagnosis of acute leukaemia

21 November 2022

119

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Multiparameter studies in lymphoid leukemias

21 November 2022

120

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Discordance between surface and cytoplasmic expression of the Leu-4 (T3) antigen in thymocytes and in blast cells from childhood T lymphoblastic malignancies

21 November 2022

121

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The T cell receptor/CD3 complex: a dynamic protein ensemble

21 November 2022

124

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The delta- and epsilon-chains of the human T3/T-cell receptor complex are distinct polypeptides

21 November 2022

127

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Rearrangement of the T-cell-receptor beta-chain gene in the diagnosis of lymphoproliferative disorders

21 November 2022

129

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms

21 November 2022

130

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Developmentally regulated rearrangement and expression of genes encoding the T cell receptor-T3 complex

21 November 2022

131

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Comparison of T cell receptor alpha, beta, and gamma gene rearrangement and expression in T cell acute lymphoblastic leukemia

21 November 2022

132

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

T cell receptor delta gene rearrangements in acute lymphoblastic leukemia

21 November 2022

137

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Chronic lymphocytic leukemia: new insights into biology and therapy

21 November 2022

143

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunoglobulins on the Surface of Neoplastic Lymphocytes

21 November 2022

144

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces

21 November 2022

147

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Chronic lymphocytic leukaemia: Clonal origin in a committed B-lymphocyte progenitor

21 November 2022

148

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Chronic lymphocytic leukemia: a monoclonal disease.

21 November 2022

149

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia

21 November 2022

158

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Phenotypic and functional characterization of human Leu1 (CD5) B cells

21 November 2022

159

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes

21 November 2022

164

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Chronic lymphocytic leukaemia cells activated in vitro reveal cellular changes that characterize B-prolymphocytic leukaemia and immunocytoma

21 November 2022

166

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia

21 November 2022

167

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes

21 November 2022

168

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells

21 November 2022

170

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Mitogen-induced switching of immunoglobulin heavy-chain class secretion in chronic B-lymphocytic leukaemia and immunocytoma cell populations

21 November 2022

171

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferations

21 November 2022

173

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Richter's syndrome. Evidence for the clonal origin of the two proliferations

21 November 2022

174

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Richter's syndrome with two different B-cell clones

21 November 2022

175

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

21 November 2022

Prolymphocytic leukaemia

177

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group

21 November 2022

179

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

T-cell prolymphocytic leukemia. Clinical and immunologic characterization

21 November 2022

180

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

T-cell prolymphocytic leukemia with helper-cell phenotype and a review of the literature

21 November 2022

181

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features

21 November 2022

182

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The B-lymphocyte nature of the hairy cell of leukaemic reticuloendotheliosis

21 November 2022

184

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

T-Lymphocyte Variant of Hairy-Cell Leukemia

21 November 2022

185

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The phenotype of the neoplastic cells of hairy cell leukemia studied with monoclonal antibodies

21 November 2022

186

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The nature of hairy cells - a study with a panel of monoclonal antibodies.

21 November 2022

187

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Phenotype study of fresh and cultured hairy cells with the use of immunologic markers and electron microscopy

21 November 2022

188

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL 3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia

21 November 2022

189

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Hairy cell leukemia: a tumor of pre-plasma cells

21 November 2022

190

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Antigens on human plasma cells identified by monoclonal antibodies

21 November 2022

191

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia

21 November 2022

192

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Monoclonal antibodies with specificity for hairy cell leukemia cells

21 November 2022

193

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunoglobulin gene rearrangements in hairy cell leukemia

21 November 2022

195

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Prognostic significance of immunologic phenotype in hairy cell leukemia: does it exist?

21 November 2022

196

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Prognostic significance of immunologic phenotype in hairy cell leukemia

21 November 2022

197

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia

21 November 2022

198

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunoglobulins on the surface of lymphoid cells in Waldenström's macroglobulinemia

21 November 2022

200

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Incipient myelomatosis or «essential« hyperglobulinemia with fibrinogenopenia - a new syndrome?

21 November 2022

201

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Monoclonal antibody characterization of plasmacytoma cells associated with T lymphocytes with a suppressor phenotype

21 November 2022

205

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

21 November 2022

206

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance

21 November 2022

208

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma

21 November 2022

209

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma

21 November 2022

210

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. Correlations with clinical features and conventional morphology

21 November 2022

213

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens

21 November 2022

217

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Malignant lymphoma simulating leukemic reticuloendotheliosis.A clinicopathologic study of ten cases

21 November 2022

218

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases

21 November 2022

219

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

A double-blind comparative immunotypic study between two institutions phenotyping non-Hodgkin's lymphomas

21 November 2022

220

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Expression of Tac antigen by non-Hodgkin's lymphomas.

21 November 2022

223

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma

21 November 2022

225

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Ki-1-positive anaplastic large-cell lymphoma: a clinicopathologic entity?

21 November 2022

226

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma

21 November 2022

227

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Malignant lymphoma, lymphoblastic

21 November 2022

228

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Convoluted lymphocytic lymphoma in adults: a clinicopathologic entity

21 November 2022

229

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Lymphoblastic Lymphoma, A Term Rekindled with New Precision

21 November 2022

230

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas

21 November 2022

231

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

NIH conference. A multidisciplinary approach to non-hodgkin's lymphomas

21 November 2022

233

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

New genetics of Burkitt's lymphoma and other non-Hodgkin's lymphomas

21 November 2022

234

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas

21 November 2022

235

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Malignant lymphoma of peripheral T-lymphocyte origin.Immunologic, pathologic, and clinical features in six patients

21 November 2022

236

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases

21 November 2022

237

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Clinical course of retrovirus-associated adult T-cell lymphoma in the United States

21 November 2022

239

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Adult T-cell lymphoma-leukaemia in Blacks from the West Indies

21 November 2022

241

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The human type-C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma

21 November 2022

243

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas

21 November 2022

244

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus

21 November 2022

245

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Functional and phenotypic studies of Japanese adult T cell leukemia cells

21 November 2022

246

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the

21 November 2022

247

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and related disorders.

21 November 2022

248

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Cutaneous T-cell lymphoma: A review

21 November 2022

249

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells

21 November 2022

251

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The Sézary syndrome: a malignant proliferation of helper T cells

21 November 2022

254

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates.

21 November 2022

255

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Chronic T cell lymphocytosis: a review of 21 cases.

21 November 2022

257

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Lymphocyte Reactivity in Hodgkin's Disease: A Lymphocyte Civil War

21 November 2022

262

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Letter: Possible T-lymphocyte origin of Reed-Sternberg cells

21 November 2022

263

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunoglobulin-positive Reed Sternberg cells in Hodgkin's disease.

21 November 2022

264

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunohistochemical demonstration of IgG in Reed-Sternberg and other cells in Hodgkin's disease

21 November 2022

265

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Letter: Origin of Hodgkin's cell

21 November 2022

266

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The nature of Reed-Sternberg cells and other malignant "reticulum" cells

21 November 2022

267

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

An immunohistological study of follicular lymphoma, reticulum cell sarcoma and Hodgkin's disease

21 November 2022

268

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Upon the nature of Hodgkin's disease and the Reed-Sternberg cell

21 November 2022

269

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Lacunar cells of nodular sclerosing Hodgkin's disease:An ultrastructural and immunohistologic study

21 November 2022

271

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The reaction of xenogeneic and monoclonal antisera with Reed-Sternberg cells

21 November 2022

272

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Exogenous Immunoglobulin and the Macrophage Origin of Reed–Sternberg Cells in Hodgkin's Disease

21 November 2022

273

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Macrophage origin of Reed-Sternberg cells: an immunohistochemical study

21 November 2022

274

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

"Sternberg-reed" giant cells of Hodgkin's Disease: cultivation in vitro, heterotransplantation, and characterization as neoplastic macrophages

21 November 2022

275

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease

21 November 2022

277

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population

21 November 2022

279

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Leukophagocytosis by Reed-Sternberg Cells in Hodgkin's Disease

21 November 2022

281

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The macrophage in Hodgkin's disease

21 November 2022

283

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Possible origin of the Reed-Sternberg cell from an interdigitating reticulum cell

21 November 2022

284

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Expression of lymphoid-associated antigens on Hodgkin's and Reed-Sternberg cells of Hodgkin's disease. An immunocytochemical study on lymph node cytospins using monoclonal antibodies

21 November 2022

286

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin's disease using fixed frozen tissues

21 November 2022

288

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Hodgkin-cell leukaemia of B-cell origin

21 November 2022

289

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain

21 November 2022

290

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma

21 November 2022

291

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The pathology of Hodgkin's disease

21 November 2022

292

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Clonal rearrangements of T-cell receptor and immunoglobulin genes and immunophenotypic antigen expression in different subclasses of Hodgkin's disease

21 November 2022

293

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Conclusions from Hodgkin-derived cell lines

21 November 2022

295

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunoglobulin gene rearrangements in Hodgkin's disease

21 November 2022

297

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders

21 November 2022

298

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Second MIC Cooperative Study Group

21 November 2022

303

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Morphologic and cytochemical characteristics of acute promyelocytic leukemia

21 November 2022

309

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Chemical Characterization and Surface Orientation of the Major Glycoprotein of the Human Erythrocyte Membrane

21 November 2022

310

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

21 November 2022

316

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunodiagnosis of acute leukemia displaying ectopic antigens: proposal for a classification of promiscuous phenotypes

21 November 2022

317

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Acute myeloblastic leukemia masquerading as null-cell acute lymphoblastic leukemia

21 November 2022

318

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10)

21 November 2022

320

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Acute leukaemia with mixed lymphoid and myeloid phenotype.

21 November 2022

324

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia

21 November 2022

328

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia

21 November 2022

329

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase

21 November 2022

332

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia

21 November 2022

333

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Hemopoietic lineage switch: v-raf oncogene converts Emu-myc transgenic B cells into macrophages

21 November 2022

335

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Relationships between B cell and myeloid differentiation. Studies with a B lymphocyte progenitor line, HAFTL-1.

21 November 2022

336

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow

21 November 2022

337

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Coexpression of p165 myeloid surface antigen and terminal deoxynucleotidyl transferase: a comparison of acute myeloid leukaemia and normal bone marrow cells

21 November 2022

338

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia

21 November 2022

339

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen

21 November 2022

341

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood

21 November 2022

342

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Phenotypic change of acute monocytic leukemia to acute lymphoblastic leukemia on therapy

21 November 2022

345

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Heterogeneity of clonogenic cells in acute myeloblastic leukemia

21 November 2022

348

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia

21 November 2022

349

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia

21 November 2022

351

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Heterogeneity of clonogenic cells in acute myeloblastic leukemia

21 November 2022

354

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells

21 November 2022

356

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The molecular biology of chronic myelogenous leukaemia

21 November 2022

360

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage

21 November 2022

361

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Cytogenetic studies on bone-marrow in chronic myeloid leukaemia

21 November 2022

362

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells

21 November 2022

365

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Involvement of the B-lymphoid system in chronic myelogenous leukaemia

21 November 2022

366

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

T cells and probably B cells arise from the malignant clone in chronic myelogenous leukemia

21 November 2022

367

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia

21 November 2022

368

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Blast crisis of chronic myeloid leukaemia (CML). II. Cell surface marker analysis of "lymphoid" and myeloid cases.

21 November 2022

370

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Origin of Chronic Myelocytic Leukemia in a Precursor of Pre-B Lymphocytes

21 November 2022

371

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

“Pre-B” phenotypes in blast crisis of Ph1 positive CML: Evidence for a pluripotential stem cell “target”

21 November 2022

372

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Terminal Transferase as a Predictor of Initial Responsiveness to Vincristine and Prednisone in Blastic Chronic Myelogenous Leukemia

21 November 2022

373

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors

21 November 2022

374

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Lymphoid crisis with T-cell phenotypes in a patient with Philadelphia chromosome negative chronic myeloid leukaemia

21 November 2022

375

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Chronic myeloid leukaemia blast crisis with T-cell features

21 November 2022

377

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications

21 November 2022

378

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Relation of “lymphoid” phenotype and response to chemotherapy incorporating vincristine-prednisolone in the acute phase of Ph1 positive leukemia

21 November 2022

379

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

The histiocytic disorders: a pathophysiologic analysis

21 November 2022

380

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

A review and reevaluation of the histiocytic disorders

21 November 2022

381

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

True histiocytic lymphoma. A report of four cases

21 November 2022

383

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Langerhans cell (eosinophilic) granulomatosis

21 November 2022

387

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Ig surface receptors and erythrophagocytic activity of histiocytosis X cellsin vitro

21 November 2022

389

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Histiocytosis X cells in eosinophilic granuloma express Ia and T6 antigens

21 November 2022

391

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Analysis of large-cell lymphomas using monoclonal and heterologous antibodies

21 November 2022

392

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Immunologic marker analysis of normal and malignant histiocytes. A comparative study of monoclonal antibodies for diagnostic purposes

21 November 2022

394

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture

21 November 2022

395

1 reference

https://api.crossref.org/works/10.1016/1040-8428(91)90029-C

21 November 2022

Identifiers

1 reference

17 August 2017

1 reference